Synanthic® (oxfendazole oral suspension) Bovine Dewormer Suspension, 22.5%

Manufacturer
Boehringer Ingelheim Animal Health USA Inc.
Effective date
2025-05-01
Label type
OTC ANIMAL DRUG LABEL
Version
12
Source
full-release
Hydrated at
2026-06-01 02:44:35

Label at a glance#

ProductSynanthic Bovine Dewormer
Active ingredientOXFENDAZOLE
Label structure13 sections

Dosage and administration

Determine the proper dose according to estimated body weight. Administer orally. The recommended dose of 2.05 mg/lb (4.5 mg/kg) is achieved when 1 mL of the suspension is given for each 110 lb (50 kg) of body weight. Examples: Cattle Weight Dose 110 lb (50 kg) 1.0 mL 220 lb (100 kg) 2.0 mL 330 lb (150 kg) 3.0 mL 440 lb (200 kg) 4.0 mL 550 lb (250 kg) 5.0 mL 660 lb (300 kg) 6.0 mL 770 lb (350 kg) 7.0 mL 880 lb (400...

Storage and handling

Store at or below 25°C (77°F). Brief excursions are permitted up to 30°C (86°F). Do not freeze.

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Each mL contains 225 mg of oxfendazole.

The entire contents of the 500 mL bottle treats 110 cattle weighing approximately 500 lbs each.

The entire contents of the 1000 mL bottle treats 220 cattle weighing approximately 500 lbs each.

Consult a veterinarian for assistance in the diagnosis, treatment and control of parasitism.

Indications:

VETERINARY INDICATIONS SECTION

SYNANTHIC Bovine Dewormer Suspension, 22.5%, is a broad-spectrum anthelmintic effective for the removal and control of the following parasites in cattle: lungworms, roundworms (including inhibited forms of Ostertagia ostertagi) and tapeworms, as indicated below:

Lungworms:

Dictyocaulus viviparus (Adult, L4)

Stomach Worms:

Barberpole Worms

Haemonchus contortus (Adult)

Haemonchus placei (Adult)

Small Stomach Worms

Trichostrongylus axei (Adult)

Brown Stomach Worms

Ostertagia ostertagi (Adult, L4, inhibited L4)

Intestinal Worms:

Nodular Worms

Oesophagostomum radiatum (Adult)

Hookworms

Bunostomum phlebotomum (Adult)

Small Intestinal Worms

Cooperia punctata (Adult, L4)

Cooperia oncophora (Adult, L4)

Cooperia surnabada (Adult, L4)

Tapeworms

Moniezia benedeni (Adult)

Administration and Dosage:

DOSAGE & ADMINISTRATION SECTION

SYNANTHIC Bovine Dewormer Suspension, 22.5%, is supplied in 500 mL and one liter packages containing 225 mg of oxfendazole per mL. The recommended dose for cattle is 2.05 mg/lb (4.5 mg/kg) of body weight. SYNANTHIC Bovine Dewormer Suspension, 22.5%, should be administered orally by accurate dose syringe at the rate of 1 mL per 110 lb (50 kg) of body weight. This product should be shaken well immediately prior to use. Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

Remove Cap and Protective Seal and Replace with Draw Off Cap Prior to Use. Do Not Squeeze Sides of Bottle. Replace the Draw Off Cap with the Initial Cap after Use.

Directions:

DOSAGE & ADMINISTRATION SECTION

Determine the proper dose according to estimated body weight. Administer orally. The recommended dose of 2.05 mg/lb (4.5 mg/kg) is achieved when 1 mL of the suspension is given for each 110 lb (50 kg) of body weight.

Examples:

Cattle Weight

Dose

110 lb (50 kg)

1.0 mL

220 lb (100 kg)

2.0 mL

330 lb (150 kg)

3.0 mL

440 lb (200 kg)

4.0 mL

550 lb (250 kg)

5.0 mL

660 lb (300 kg)

6.0 mL

770 lb (350 kg)

7.0 mL

880 lb (400 kg)

8.0 mL

990 lb (450 kg)

9.0 mL

1100 lb (500 kg)

10.0 mL

Treatment may be repeated in 4–6 weeks.

Residue Warnings:

RESIDUE WARNING SECTION

Cattle must not be slaughtered until 7 days after treatment. Because a withdrawal time in milk has not been established, do not use in female dairy cattle of breeding age.

Other Warnings

WARNINGS SECTION

Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers.

Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance.

Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd/flock, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method).

A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

Caution:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Use only as directed. Keep out of reach of children. Not for human use.

Safety:

CONTRAINDICATIONS SECTION

There are no contraindications for the use of SYNANTHIC Bovine Dewormer Suspension, 22.5%, in cattle.

Shake well before use.

Storage:

STORAGE AND HANDLING SECTION

Store at or below 25°C (77°F). Brief excursions are permitted up to 30°C (86°F). Do not freeze.

SPL UNCLASSIFIED SECTION

Restricted Drug (California) – Use Only as Directed

© 2019 Boehringer Ingelheim Animal Health USA Inc. All rights reserved.

SYNANTHIC and the Cattle Head Logo are registered trademarks of Boehringer Ingelheim Animal Health USA Inc.

86993449

383208-02

SPL UNCLASSIFIED SECTION

Marketed by:
Boehringer Ingelheim Animal Health USA Inc.
Duluth, GA 30096

Principal Display Panel – Container Label 500 mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0010-3832-01

SYNANTHIC®

(oxfendazole oral suspension)

Bovine Dewormer Suspension, 22.5%

For Animal Use Only

Net Contents: 500 mL

Approved by FDA under NADA # 140-854

Picture of 500 mL label - left and center panel
Picture of 500 mL label - left and center panel
Picture of 500 mL label - right panel
Picture of 500 mL label - right panel

Principal Display Panel – Display Carton 500 mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0010-3832-01

SYNANTHIC®

(oxfendazole oral suspension)

Bovine Dewormer Suspension, 22.5%

For Animal Use Only

Net Contents: 500 mL

Approved by FDA under NADA # 140-854

Picture of 500 ml display carton - front and side panel
Picture of 500 ml display carton - front and side panel
Picture of 500 mL display carton - back and side panel
Picture of 500 mL display carton - back and side panel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1095405oxfendazole 225 MG/ML Oral Suspension [Synanthic]SBD12
855508oxfendazole 225 MG/ML Oral SuspensionSCD12
1095405Synanthic 225 MG/ML Oral SuspensionSY12
1095405Synanthic Bovine Dewormer 22.5 % Oral SuspensionSY12

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0010-3832-01Synanthic Bovine Dewormer500 mL in 1 BOTTLE, PLASTICSUSPENSION50012
0010-3832-01Synanthic Bovine Dewormer1 in 1 CARTONSUSPENSION112
0010-3832-02Synanthic Bovine Dewormer1000 mL in 1 BOTTLE, PLASTICSUSPENSION100012
0010-3832-02Synanthic Bovine Dewormer1 in 1 CARTONSUSPENSION112
0010-3832-03Synanthic Bovine Dewormer4000 mL in 1 BOTTLE, PLASTICSUSPENSION400012

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0010-3832SYNANTHIC BOVINE DEWORMER (OXFENDAZOLE) SUSPENSION [BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.]125 package rows20250503_152cde64-ff22-4a3e-bb78-65e159dbe6b6.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OXFENDAZOLEACTIVE INGREDIENTOMP2H17F9E3
OXFENDAZOLEACTIVE MOIETYOMP2H17F9E3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0010-38320010-3832-01, 0010-3832-02, 0010-3832-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
OXFENDAZOLEOMP2H17F9EACTIB

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.